Generic depression patch tested against brand in small study
NCT ID NCT06607744
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a generic selegiline skin patch works the same as the brand-name EMSAM patch. Twelve healthy adults wore both patches to measure how much drug got into their blood and to check for skin irritation. The goal was to see if the generic version is a safe and effective alternative.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MDD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Ampang
Ampang, Selangor, 68000, Malaysia
-
Sarawak General Hospital
Samoran, Sarawak, 94300, Malaysia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a blood test spot teen suicide risk?
- Could a flickering light headset lift depression?
- Online depression program for orthopedic patients pulled before starting
- Could a zap to your face lift your mood? new trial explores FES for depression
- Could a facial zapping device treat depression at home?
- New depression drug LV232 enters Mid-Stage trial